IVT along with Hexamer Therapeutics has developed a new generation of peptide vaccines with a versatile platform technology for infectious diseases and cancers. Innovative Vaccine Technologies is working with U.S. and global leaders in a dedicated effort to end the Covid-19 pandemic as well as assist in providing vaccines and therapeutics to combat certain cancers. Innovative Vaccine Technologies identifies and partners with industry leaders in peptide production to optimize vaccine manufacturing and distribution.